ghra 2018 logo     


Announcing the Call for 2020 Nominations of Global Health Repurposing Award Honorees:


Awards will be given to industry leaders, scientists, philanthropists and organizations driving improvements in clinical care through repurposing at several events throughout 2020, part of Cures Within Reach’s largest annual fundraiser.  These events celebrate our collective commitment to patient impact through repurposing. In 2020, Cures Within Reach will honor these three recipients in locations that best celebrate the honorees in their own communities, with the people who best can help us honor them.


Nominations Open Now Through January 10, 2020

3eventcollage

***


To learn about sponsorship opportunities, email GHRA@cureswithinreach.org

                   



Janet Davison Rowley Patient Impact Research Award

The Janet Davison Rowley Patient Impact Research Award is given to one or more researchers, clinicians or computational biologists who have created positive patient impact through repurposing research. We honor the impact Dr. Rowley (1925-2013) had on patients through her clinical care and medical research, including her pioneering work that led to the creation of drugs that were later repurposed for additional indications.

Previous awardees include ▼

  • Dr. Denise Faustman, Massachusetts General Hospital and Harvard Medical School
  • Dr. Scott Weir, The University of Kansas Cancer Center and the University of Kansas Medical Center (See a short video about his research at the top of this page!)
  • Dr. Berish Rubin & Dr. Sylvia Anderson, Fordham University
  • Dr. Marty St. Clair, Viiv Healthcare
  • Dr. Vincent Rajkumar, Mayo Clinic
  • Dr. James Surmeier and Dr. Tanya Simuni, Northwestern University
  • Dr. David Teachey, Children’s Hospital of Philadelphia 

The researcher, clinician and/or computational biologist selected should fit the following profile ▼

  • Has successfully repurposed a drug, device or nutraceutical for human clinical use, which is either used off-label or has been approved by the FDA or other regulatory agency; has made significant advancements in repurposing research; and/or is a recognized thought leader in repurposing research
  • Has published repurposing research data in the scientific literature
  • Patients who use or used a repurposed treatment discovered and/or advanced by the nominee enjoy an increased quality and/or length of life
  • Will work with Cures Within Reach on public recognition of the award

CA logo graphic only

 


Golan Christie Taglia Patient Impact Philanthropy Award

The Golan Christie Taglia Patient Impact Philanthropy Award is given to an individual, group or organization that has created positive patient impact by advocating for patients or contributing to the growth of repurposing research through financial, operational or professional philanthropic support. Named in honor of Golan Christie Taglia LLP in gratitude for their many years of financial and in-kind support for Cures Within Reach, helping us to grow and thrive.

Previous awardees include ▼

  • The Alzheimer's Drug Discovery Foundation
  • The Leukemia & Lymphoma Society
  • FRAXA Research Foundation
  • Dr. Nicolas Sireau, with Professor Lakshminarayan Ranganath, AKU Society
  • The Robert Wood Johnson Foundation
  • George and Judy Goldman, Goldman Philanthropic Partnerships
  • Golan Christie Taglia LLP

The individual, group or organization selected should fit the following profile ▼

  • Be a recognized leader in an advocacy, research, healthcare, philanthropic or non-governmental (NGO) organization endeavor, or be a supporter of such an endeavor
  • Has made significant philanthropic contributions and/or created fundraising that have resulted in the advancement of repurposing
  • Has brought together various stakeholders to create an increased quality and/or length of life for patients
  • Will work with Cures Within Reach on public recognition of the award

CA logo graphic only

 


Patient Impact Industry Award

The Patient Impact Industry Award is given to an industry individual, group or organization that has created positive patient impact by contributing to the growth and profile of repurposing research within the healthcare industry, through financial, operational and/or collaborative support. Nominees may represent any size of industry organization, from start up to large pharmaceutical companies. In addition, nominees may also represent any sector that impacts repurposing research, including biotech, pharma and indutry service / support providers.

Previous awardees include ▼

  • Jazz Pharmaceuticals
  • Novartis
  • Timothy P. Walbert, Horizon Therapeutics plc
  • Dr. Jerome B. Zeldis, Sorrento Therapeutics, formerly of Celgene Global Health and Celgene Corporation
  • Dr. Richard DiMarchi, University of Indiana, formerly of Eli Lily
  • Dr. Norbert Riedel, Aptinyx Inc., formerly of Baxter International
  • Michael S. Rosen, Rosen Bioscience Strategies, formerly of Illinois Science + Technology Park and Forest City Realty Trust

The individual, group or organization selected should fit the following profile ▼

  • Is or was in a significant leadership position in the healthcare industry and has demonstrated a commitment to collaboration, service and/or support for repurposing research
  • Focused the attention of the healthcare industry, and/or their own group or organization and similar groups or organizations, on improving the lives of patients through repurposing
  • Patients who use or used a repurposed treatment supported by this nominee enjoy an increased quality and/or length of life
  • Will work with Cures Within Reach on public recognition of the award

CA logo graphic only

 


 Questions? Contact Clare Thibodeaux, PhD, Director of Scientific Affairs

clare@cureswithinreach.org or 847-745-1250

 

Click here to sign up for our eNewsletter today!

Please include your Full Name* and Email Address*

*required

If the link above doesn't work, please contact our Admin support at admin@cureswithinreach.org with your Full Name and Email Address to sign up!

 

Cures Within Reach

134 N. LaSalle, #1130
Chicago, IL 60602

info@cureswithinreach.org

All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes. 

Partnership for Cures DBA Cures Within Reach is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.

 

Monday the 24th. Copyright 2018 Cures Within Reach.